Tag: incidence

Rogers continuera de vendre des services de connectivité et de centre de données dans les installations

- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD

ATLANTA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Atlantic American Corporation (Nasdaq- AAME) today reported net income of $3.3 million, or $0.15 per diluted share, for the three month period ended June 30, 2025 compared to net loss of ($0.7) million, or ($0.04) per diluted share, for the comparable period in 2024. The Company had net income of $4.1 million, or $0.19 per diluted share, for the six month period ended June 30, 2025, compared to net loss of ($2.7) million, or ($0.14) per diluted share, for the six month period ended June 30, 2024. The increase in net income for the three month and six month periods ended June 30, 2025 was primarily the result of increases in premium revenue, coupled with an increase in unrealized gains on equity securities.

Ad hoc announcement pursuant to Art. 53 LR

Nyxoah Annonce ses Résultats Préliminaires pour le Deuxième Trimestre 2025 

MONTRÉAL, 08 août 2025 (GLOBE NEWSWIRE) -- Les Industries Dorel inc. (TSX : DII.B, DII.A) a annoncé aujourd'hui ses résultats financiers pour le deuxième trimestre et les six mois clos le 30 juin 2025.

INFORMATIONS PRIVILÉGIÉES
INFORMATIONS RÉGLEMENTÉES

JERUSALEM, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business updates for the quarter ended June 30, 2025.